These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 34245901)

  • 41. Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.
    Ramai D; Zakhia K; Fields PJ; Ofosu A; Patel G; Shahnazarian V; Lai JK; Dhaliwal A; Reddy M; Chang S
    Dig Dis Sci; 2021 Feb; 66(2):369-380. PubMed ID: 32166622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic].
    Nagy GG; Tudlik Z; Gergely L; Kónya J; Orosi P; Rákóczi É; Szabó J; Várvölgyi C; Vitális E; Paragh G
    Orv Hetil; 2020 Nov; 161(44):1858-1871. PubMed ID: 33130602
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Faecal microbiota transplantation for Clostridioides difficile infection].
    Waldbaum C; López F; Antelo P; Sorda J
    Medicina (B Aires); 2020; 80(6):633-639. PubMed ID: 33254107
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection.
    Cheng YW; Phelps E; Nemes S; Rogers N; Sagi S; Bohm M; El-Halabi M; Allegretti JR; Kassam Z; Xu H; Fischer M
    Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2234-2243.e1. PubMed ID: 31923639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness analysis of sequential fecal microbiota transplantation for fulminant Clostridioides difficile infection.
    Gupta S; Zhu J; McCarty TR; Pruce J; Kassam Z; Kelly C; Fischer M; Allegretti JR
    J Gastroenterol Hepatol; 2021 Sep; 36(9):2432-2440. PubMed ID: 33682170
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Probiotics for prevention of Clostridium difficile infection.
    Mills JP; Rao K; Young VB
    Curr Opin Gastroenterol; 2018 Jan; 34(1):3-10. PubMed ID: 29189354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fecal microbiota transplantation and Clostridioides difficile infection among privately insured patients in the United States.
    El Halabi J; Palmer N; Fox K; Kohane I; Farhat MR
    J Gastroenterol; 2022 Jan; 57(1):10-18. PubMed ID: 34495400
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clostridioides difficile: updated recommendations].
    Barbut F; Eckert C; Lalande V; Le Neindre K; Couturier J
    Rev Prat; 2022 Sep; 72(7):703-709. PubMed ID: 36511953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Secondary prophylaxis for Clostridioides difficile infection for patients on non-C. difficile antibiotics: a retrospective cohort study.
    Najjar-Debbiny R; Barnett-Griness O; Arbel A; Cohen S; Weber G; Amar M; Yassin R; Greenfeld I; Shehadeh S; Saliba W
    Microbes Infect; 2024; 26(5-6):105349. PubMed ID: 38719086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pediatric Fecal Microbiota Transplantation in Recurrent
    Parnell JM; Nicholson MR; Kellermayer R; Kahn SA
    Pediatr Ann; 2021 Dec; 50(12):e515-e521. PubMed ID: 34889135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fecal microbiota transplantation may reduce the mortality of patients with severe and fulminant Clostridioides difficile infection compared to standard-of-care antibiotics in a community hospital.
    Mironova M; Ehrlich AC; Grinspan A; Protano MA
    J Dig Dis; 2022 Aug; 23(8-9):500-505. PubMed ID: 36183340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical practice guidelines for Clostridioides (Clostridium) difficile infection and fecal microbiota transplant protocol - recommendations of the Polish Society od Epidemiology and Infectious Diseases.
    Piekarska A; Panasiuk A; Stępień PM
    Przegl Epidemiol; 2020; 74(1):69-87. PubMed ID: 32500988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: experience with lyophilized oral capsules.
    Reigadas E; Bouza E; Olmedo M; Vázquez-Cuesta S; Villar-Gómara L; Alcalá L; Marín M; Rodríguez-Fernández S; Valerio M; Muñoz P
    J Hosp Infect; 2020 Jun; 105(2):319-324. PubMed ID: 31883938
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clostridioides Difficile: A Concise Review of Best Practices and Updates.
    Yakout A; Bi Y; Harris DM
    J Prim Care Community Health; 2024; 15():21501319241249645. PubMed ID: 38726585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Faecal microbiota transplantation for recurrent
    Baunwall SMD; Lee MM; Eriksen MK; Mullish BH; Marchesi JR; Dahlerup JF; Hvas CL
    EClinicalMedicine; 2020 Dec; 29-30():100642. PubMed ID: 33437951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prolonged oral vancomycin for secondary prophylaxis of relapsing Clostridium difficile infection.
    Zhang K; Beckett P; Abouanaser S; Stankus V; Lee C; Smieja M
    BMC Infect Dis; 2019 Jan; 19(1):51. PubMed ID: 30642269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention and treatment of C. difficile in cancer patients.
    Puerta-Alcalde P; Garcia-Vidal C; Soriano A
    Curr Opin Infect Dis; 2023 Dec; 36(6):473-480. PubMed ID: 37527003
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Liu Y; Chen M
    Can J Gastroenterol Hepatol; 2022; 2022():4209442. PubMed ID: 35711246
    [No Abstract]   [Full Text] [Related]  

  • 59. Clostridioides difficile infections; new treatments and future perspectives.
    Normington C; Chilton CH; Buckley AM
    Curr Opin Gastroenterol; 2024 Jan; 40(1):7-13. PubMed ID: 37942659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recognition and attitudes of Korean physicians toward fecal microbiota transplantation: a survey study.
    Gweon TG; Lee YJ; Yim SK; Kim SY; Choi CH; Cho YS;
    Korean J Intern Med; 2023 Jan; 38(1):48-55. PubMed ID: 36353787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.